ASPHALION EXPERTISE AS REGULATORY PARTNER IN EU-FUNDED PROGRAMMES

The deadline for the first calls regarding HORIZON EU-granted projects, September the 21st, is approaching. Every call needs a mix of partners in order to fill its requirements. If at this stage you still do not have a Regulatory partner for your project, we suggest you contact us.

The deadline for the first calls regarding HORIZON EU-granted projects, September the 21st, is approaching. Every call needs a mix of partners in order to fill its requirements. If at this stage you still do not have a Regulatory partner for your project, we suggest you contact us.
August 30, 2021

The deadline for the first calls regarding HORIZON EU-granted projects, September the 21st, is approaching. Every call needs a mix of partners in order to fill its requirements. If at this stage you still do not have a Regulatory partner for your project, we suggest you contact us.

At ASPHALION, we have experience as Regulatory Partners in more than 14 European funded projects, providing Regulatory Affairs support throughout the whole project duration. As global regulatory partners, we have experience in the regulatory activities from early development and proof of concept throughout clinical phases and marketing approval for innovative medicinal products and medical devices, including: ATMPs, nanomaterials, digital health solutions, diagnostic devices, etc.

The success we are experiencing with all these projects make us willing to continue with new challenging work. We will be more than glad to discuss future projects in this new Horizon Europe scenario with you!​

Whether you are planning to apply and you would like to add a regulatory partner to the project, or if you are interested in knowing more about ASPHALION and our European granted projects expertise, do not hesitate to contact us at:

horizon@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

The METHYLOMIC project has been kicked off!

The efficiency and cost-effectiveness will also be assessed in great detail, and experts will guide regulatory approval to ensure delivery of the first epigenetic kit personalised treatment of CD.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting